Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.


NYSE:PFE - Post by User

Post by jonweston Jan 13, 2021 11:31pm
166 Views
Post# 32291748

PFE never moves up

PFE never moves up
Even stupid children would know PFE is so undervalued. 
 
Without Vaccine, PFE was $40 / share.
With Vaccine, it is now 36 / share. 
 
PFE earned some +20 Billion extra money. With this forecast, it is only 36/share. Last year when it didn't have +20 billion, it was 40/ share.
 
The investors are saying about future value. It has future value. Some different versions of Covid-19 will always come out. PFE will continue to make Vaccines for all of them. The extra cash PFE earns will be reinvested into R&D, so PFE will always make vaccines before other competitors. Therefore, PFE has great future potential. 
 
Still, investors continue to throw the stock away whenever the percent climes about 0.01 %. Whenever PFE rises some 0.01 cents, they quickly sell around 1 M volume. Do they think PFE is some form of garbage or what? The real garbage stock is Tesla. $ 1 million sale growth pushes the stock some 800% increase. PFE gets 20 billion sales growth but, it went down by 10%. It will fall to some $33 / share next week. 
 
For PFE to increase 1%, 20 billion dollar increase isn't enough. To satisfy investors, PFE must generate around 1 Trillion revenue and 500 billion net income. 
 
In comparison, Tesla only needs to generate some 1 million revenue and 50K net income to increase its stock value by 1000%. Ridiculous!
<< Previous
Bullboard Posts
Next >>